Revive Selects Clinical Sites for FDA Phase 3 Clinical Trials
This morning Revive Therapeutics Ltd (CSE: RVV, OTV: RVVTF), announced they have selected five clinical sites in Florida, Texas and
Read moreThis morning Revive Therapeutics Ltd (CSE: RVV, OTV: RVVTF), announced they have selected five clinical sites in Florida, Texas and
Read moreThis morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National Interest Strategic Project by the Government
Read moreAfter the market, Bloomberg reported the SEC is assessing the merits of the accusations made by short-seller Hindenburg Research. The claims
Read moreYesterday Kontrol Energy Corp (CSE:KNR) announced they received positive lab results for their live COVID-19 air testing unit, BioCloud. Investors
Read moreThis morning Nikola (NASDAQ: NKLA) shareholders woke up to news that the company was the latest target of Hindenberg Research.
Read moreThis morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to dual list their stock on
Read moreOn August 26th Gatekeeper Systems Inc. (TSXV: GSI) announced their intentions to complete a non-brokered private placement of $5 million at
Read moreThis week Digimax (CSE: DIGI) announced they have executed their merger with DataNavee. DigiMax is a CSE issuer focused on
Read moreThis morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial protocol to their independent Institutional
Read moreThis morning Eguana Technologies (TSXV: EGT) released their third quarter earnings for the period ended June 30, 2020. The company,
Read more